A Low-cost Microfluidic Approach for Single Cell Analysis of Rare Cells

Publication Type:
Thesis
Issue Date:
2023
Full metadata record
Traditional biopsy methods, while detailed, are often invasive, causing discomfort and not always feasible for deep-seated tissues. Liquid biopsy, detecting rare cells in body fluids, offers a less invasive alternative for diagnosing and monitoring various conditions, including cancer and viral infections. However, the rarity of these cells in peripheral blood and the complexity of existing isolation and analysis techniques pose significant challenges. Addressing these challenges, the thesis presents capillary force-based, self-driving static droplet microfluidic devices for blood sample fractionation and single-cell isolation. These devices feature sub-nanolitre chambers for single-cell analysis in confined volumes. A workflow using common lab equipment was developed for single-cell molecular studies. The research also includes a detailed study on cell metabolism, particularly focusing on lactate production as a biomarker to distinguish cancer cells from normal blood cells, facilitated by the miniaturisation of the microfluidic devices. The methodology was validated using healthy human blood, preclinical mammary mouse models, and a MATLAB-based program for automated droplet analysis. Additionally, the thesis investigates lactate production's correlation with the epithelial-mesenchymal transition (EMT) state of cells, potentially aiding in understanding patient disease states.
Please use this identifier to cite or link to this item: